|Videos|April 20, 2023
Advances in Neurology, Contributions to Brain Health: Costantino Iadecola, MD
Author(s)Costantino Iadecola, MD
The director of the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine talked about brain health in relation to vascular health ahead of the 2023 AAN annual meeting. [WATCH TIME: 3 minutes]
Advertisement
WATCH TIME: 3 minutes
"Every country and every neurological or medical community is focused on brain health. They are continuously consensus statements coming from a variety of countries about what we should do to preserve brain health."
The 2023 American Academy of Neurology (AAN) Annual Meeting , April 22-27, in Boston, Massachusetts, is expected to comprise a broad range of topics in neurology, with community representation from the different subspecialities. The program is set up to be predominantly clinical, and geared toward clinician practice. During the meeting, there will be a variety of educational courses and sessions for clinicians to help them learn about the different topics related to neurological conditions.
Brain health with neurodegenerative diseases, specifically Alzheimer disease , will be among the topics discussed at the meeting. This will cover the latest developments in factors that contribute to damaging the brain, particularly the impact of vascular contributions. On the last day of the meeting, Costantino Iadecola, MD , will give a talk in one of the plenary sessions on advances in neurology about brain health. He plans to present evidence of the causes of brain damage and strategies to counteract threats to the brain.
Iadecola, the Ann Parish Titzell Professor of Neuroscience and director of the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine, recently sat down with NeurologyLive® in an interview before the meeting to talk about his presentation in regard to the topic of brain health. He talked about the importance of vascular health in regard to the aging population, who are more at risk for brain diseases. He also spoke about the types of pathologies that cause damage in the brain and what clinicians should keep in mind with their patients.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
2
Expanding the Alzheimer Drug Development Pipeline
3
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
4
NeurologyLive® Friday 5 — September 12, 2025
5